Connection

David Mahvi to Antibody-Dependent Cell Cytotoxicity

Back to Details
This is a "connection" page, showing publications David Mahvi has written about Antibody-Dependent Cell Cytotoxicity.
David Mahvi
Connection Strength
0.016
Antibody-Dependent Cell Cytotoxicity
  1. Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma. Cancer Immunol Immunother. 2006 Jul; 55(7):761-74.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.